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ABSTRACT 
 
Background: Iron deficiency was a major cause of anemia in pregnancy. The incidence of large 
deficiency anemia was mostly experienced in pregnancy which can result in general hematological 
disorders with considerable complications both for the mother and the fetus. This study aimed to 
compare the efficacy of intravenous iron administration and oral iron for the treatment of iron defi-
ciency anemia in pregnancy. 
Subjects and Method: This was a meta-analysis conducted using PRISMA systematic guideli-
nes. The process of searching articles was carried out between 2000 and 2018 using a database se-
arch engine consisting of; PubMed, Science Direct, Springer Link, and Google Scholar. Based on 
database searches, nine articles that met the Randomized Control Trial (RCT) criteria and study 
were conducted in lower middle income countries. This study involved 967 samples divided into 
two groups of 484 intravenous iron and 483 oral iron. The analysis was carried out with Review 
Manager (RevMan) software 5.3. The results were assessed for Mean Difference (MD) and the 
analysis was carried out for heterogeneity. 
Results: There was a high heterogeneity between experiments (I2= 91%; p <0.001) so that Ran-
dom Effects Model (REM) was used. Intravenous iron administration can increase hemoglobin 
levels 0.70 g / dL higher than oral iron administration, and it was statistically significant (MD 0.70; 
95 % CI: 0.37 to 1.02; p<0.001). 
Conclusion: Intravenous iron administration was more effective than oral iron for the treatment 
of iron deficiency anemia in pregnancy. Pregnant women given intravenous iron more quickly 
reach the desired hemoglobin level target than oral iron. 
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BACKGROUND 
Anemia in pregnancy is the most common 
and wide spread public health problem, 
anemia is estimated to affect almost 40% of 
pregnancies worldwide and is associated 
with a significant increased risk of perinatal 
morbidity and mortality (Haider et al., 
2013). Anemia affects globally 1.62 billion 
people worldwide, associated with 24.8% of 
the world's population (Pavord et al., 2012). 
Anemia has been defined as a limit of 
hemoglobin levels in pregnancy. The World 
Health Organization (WHO) defines anemia 
as a hemoglobin level <11 g / dL while in 
pregnancy <10g / dL in the first trimester, 
<10.5 g / dL in the second trimester and 10 
g / dL in the third trimester, in recognition 
of the maximum physiological hemodilution 
in the second trimester (Pavord et al., 
2012). 
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Based on global data, 56% of pregnant 
women are in low status and middle and 
lower income countries are anemic (Pas-
richa et al., 2013). Anemia is one of the risk 
factors that contribute to 50% of maternal 
deaths (Khaskheli et al., 2016). Pregnant 
women are the population most vulnerable 
to developing iron deficiency anemia. He-
alth interventions have been carried out on 
a large scale, but the incidence of iron defi-
ciency anemia continues to increase in de-
veloping countries (Bilimale et al., 2010). 
Pregnancy requires a lot of iron, as the 
pregnant women have the risk of developing 
iron deficiency anemia. During pregnancy, 
iron deficiency anemia is associated with an 
increased risk of preterm birth, low birth 
weight, fetal growth restriction, and increa-
sed and maternal mortality. Iron deficiency 
can also cause a person to experience post-
partum iron deficiency anemia, peripartum 
which can trigger heart failure and infection 
(Camaschella, 2015). 
Supplements are needed for pregnant 
women who are anemic or non-anemic such 
as iron, folic acid or both. Based on the ro-
ute of administration of iron can be taken 
orally and intravenous injection (II) which 
is generally used clinically in practice 
(Qassim et al., 2017). Additional supple-
ments are needed for pregnant women with 
anemia. To prevent iron deficiency in preg-
nancy, experts recommend consuming 30 
mg of iron every day (Rahman et al., 2016). 
The use of oral iron is considered to be 
the first treatment due to low temperature 
and low cost, but its use is limited by gastro-
intestinal side effects that can affect compli-
ance and low absorption rates. Intravenous 
iron is considered to be a useful option 
when rapid handling is needed (Qassim et 
al., 2017). Fear of anaphylaxis (no formu-
lation that has the highest level of safety of 
the Food and Drug Administration or FDA) 
in intravenous (II) use no adverse side 
effects have been reported in thousands of 
patients (Tolkien et al., 2015).  
Recently, the Cochrane Collaboration 
reported that high incidence and high di-
sease burden associated with iron deficiency 
anemia in pregnancy have a lack of trials of 
the quality of the effects of maternal and ne-
onatal clinical administration of iron in wo-
men with anemia (Reveiz et al., 2012). Iron 
deficiency in pregnant women affects grow-
th and brain development, cognitive, neona-
tal behavior (Congdon et al., 2012). The ne-
gative effects of iron deficiency anemia du-
ring childbirth are associated with an incre-
ased risk of Sectio Caesarea (SC) which ad-
versely affects neonatal (Drukker et al., 
2015). 
This study aimed to examine the effi-
cacy of intravenous iron administration 
than oral iron on hemoglobin levels in preg-
nant women with iron-deficiency anemia in 
lower middle income countries. 
 
SUBJECTS AND METHOD 
1. Study Design 
This was a systematic review and meta-ana-
lysis. The articles in this study were obtai-
ned from database of several indexes inclu-
ded; PubMed, Science Direct, Springer 
Link, and Google Scholar. The articles were 
published between 2000 and 2018. Sear-
ching was using the following keywords: 
“Pregnancy” AND “anemia, iron deficiency”, 
“oral iron”, “intravenous iron”, “intravenous 
iron therapy”, “Pregnancy”, “anemia”, 
“treatment”, “randomized control trial”, 
“iron sucrose”, “anemia in pregnancy”, 
”treatment of anemia in pregnancy” AND 
“intravenous iron inpregnancy”, “MeSH”. 
data of this study is published articles 
between 2000 and 2018 which the study 
was carried out in lower middle income 
countries found in the databases which 
were; PubMed, Science Direct, Springer 
Link, and Google Scholar. 
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2. Inclusion Criteria 
The inclusion criteria in this study were full 
paper articles with Randomized Controlled 
Trial (RCT), therapy oral iron with com-
parised of intravenous substance therapy, 
and pregnant women with anemia (hemo-
globin level <10.5 g / dL). Articles with he-
moglobin levels measured after 4 weeks. 
3. Exclusion Criteria 
The study was conducted in cross section, 
case control, quasi experimental, study pro-
tocol or pilot study. The therapy given com-
pared between 2 II and 2 oral. 
4. Definition of Operational Variables 
Anemia was defined as the limit of hemo-
globin levels in pregnancy. The World He-
alth Organization (WHO) defines anemia as 
a hemoglobin level <11g / dL while in preg-
nancy <10 g / dL in the first trimester, 
<10.5 g / dL in the second trimester and 10 
g / dL in the third trimester, in recognition 
of the maximum physiological hemodilution 
in the second trimester (Pavord et al., 
2012). 
This study involved two treatment 
groups that would be compared. The intra-
venous group includes iron sucrose, ferric 
carboxymaltose, and LWM iron dextran, the 
iron group orally includes ferrous sulfate, 
ferrous fumerate, and ferrous ascorbate. 
The scale of measurement of results from 
intravenous and oral were presented in the 
form of continuous data. 
5. Data Analysis  
Data analysis was carried out by using the 
Review Manager (Rev-Man) software 5.3 
released by the Cochrane Collaboration. 
RevMan is used to calculate Mean Diffe-
rence (MD) as a whole. 
 
RESULTS 
There were 815 identified articles which can 
be seen in Figure 1. After going through the 
multiple article deletion process, 29 articles 
were found, the filtered articles were 786 
articles. Based on the results of the filtered 
article, there were 761 articles that must be 
issued and 25 articles that were considered 
to fulfill the requirements for full text 
review process. 
After an assessment of full text ar-
ticles, articles were found that were targeted 
not for pregnant women but for women 
before pregnancy and post partum mothers. 
The outcome of the study did not match the 
criteria applied, the article was issued 
because it did not include the treatment 
time.
 
 
 
 
 
 
 
 
 
 
Figure 1. Flowchart Review Process 
 
Articles issued (n=15) 
1. Not included in middle to lower income 
countries = 11 
2. The article is not about pregnant women = 3 
3. Outcome is not appropriate= 1 
Articles identified through database search (n=815) 
Filtered articles (n=786) 
Full text articles that are considered eligible (n=25) 
 
 
(n=    ) Articles included in qualitative synthesis (n=10) 
 
 
(n=    ) Articles included in the quantitative synthesis of 
meta-analysis (n=9) 
 
(n=    ) 
Articles issued (n=761) 
1. The title is irrelevant = 739 
2. Not full text= 8 
3. Not in English version = 14 
Deleting multiple data (n=29) 
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Articles that fulfilled the qualitative requi-
rements were reviewed and one article was 
issued because it did not include the avera-
ge after treatment and standard deviation 
(SD) needed to determine the effects of 
treatment. The article only included the 
difference in improvement after treatment 
so that analysis cannot be done by using 
mean difference (MD). 
From the final results of the article 
review process, there were 9 articles that 
fulfilled the quantitative requirements to 
conduct a meta-analysis of intravenous 
iron efficacy compared to oral iron on in-
creased hemoglobin levels in pregnant wo-
men with iron-deficiency anemia. Articles 
obtained from the results of the review 
were studies originating from countries in-
cluded in middle and lower income coun-
tries. 
The following was an overview of the 
study area obtained from articles that have 
fulfilled the requirements: India, there 
were eight studies conducted in India. In 
addition, there was one study conducted in 
the country of Egypt. Based on the des-
cription, the regions included in middle 
and lower income countries can be seen in 
Figure 2. to find out the map of the area 
and the number of study subjects included 
in the meta-analysis. 
 
Figure 2. General Description of the Study Area 
 
Based on Figure 2, in the middle to lower 
income countries included in this meta-
analysis, it consisted of only two countries, 
namely India and Egypt. The Indian 
countries included in the subject of this 
study consisted of 901 pregnant women 
with iron-deficiency anemia and in Egypt 
there were 66 pregnant women who were 
included in the study subjects to see the 
efficacy of intravenous iron administration 
compared to oral iron against increased 
hemoglobin levels in anemia pregnant 
women with deficiency iron. 
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The results of the meta-analysis were 
presented in forest plot. The forest plot 
presented a diagram that showed 
information from each study studied and 
estimates of overall results (Akobeng in 
Murti, 2018). In addition, this meta-ana-
lysis also presented a funnel plot, a 
diagram that illustrated the possibility of 
publication bias by displaying the relation 
between the effect size of the study and the 
sample size of the various studies. 
The publication bias in the funnel 
plot can be assessed by looking at the 
funnel shape asymmetry, the number of 
points on the right and left side compared 
to the standard error (Murti, 2018). 
Table 1. Summary source of intravenous iron compared to oral iron to increased 
hemoglobin levels 
Author and 
Year 
Location/ 
Country 
Total Population 
Source 
 
Inclusion 
Criteria 
(Hb,g/dL) 
 
Content 
Result 
II Oral IV Oral 
Abhilashi, et 
al.(2014) 
Pondicherr
y, India 
50 50 JIPMER in the 
Department of Obs-
tetrics and Gynae-
cology 
6.0-8.0 
 
IV: iron 
sucrose 
Oral: ferrous 
sulfate 
Mean: 
9.48 
SD: 
0.7 
Mean: 
9.15 
SD: 
0.7 
Bhavi, et al. 
(2017) 
India 56 56 Antenatal clinic at 
Shri B.M.Patil 
Medical college 
Hospital, Bijapu 
7.0-11.0 IV: iron 
sucrose 
Oral: ferrous 
fumarate 
Mean: 
10.64 
SD: 
1.3 
Mean: 
10.06 
SD: 
1.03 
Darwish, et 
al. (2017) 
Assiut, 
Egypt 
33 33 Assiut University 7.0-10.0 IV: LMW iron 
dextran 
Oral: ferrous 
fumerate 
Mean: 
10.29 
SD: 
0.86 
Mean: 
9.51 
SD: 
0.77 
Gupta, et al. 
(2013) 
New Delhi, 
India, 
50 50 Lok Nayak Hospital 7.0-9.0 IV: iron 
sucrose 
Oral: ferrous 
sulfate 
Mean: 
9.8 
SD: 
0.46 
Mean: 
9.18 
SD: 
0.55 
Kochhar, et 
al. (2012) 
New Delhi, 
India 
50 50 Department of 
Obstetrics and 
Gynaecology, Lady 
Hardinge Medical 
College and Smt. 
Kucheta Kriplani 
Hospital 
7.0-9.0 
 
IV: iron 
sucrose 
Oral: ferrous 
sulfate 
 
Mean: 
12.8 
SD: 
1.1 
Mean: 
10.7 
SD: 
0.7 
Mehta, et al. 
(2014) 
India 75 75 Department of 
Obstetrics and 
Gynecology, Surat 
Municipal Institute 
of Medical Edu-
cation and Study 
SMIMER 
<8.0 IV: iron 
sucrose 
Oral: ferrous 
sulfate 
Mean: 
10.64 
SD: 
0.71 
Mean: 
10.17 
SD: 
0.54 
Neeru, et al. 
(2012) 
India 45 44 KMC Hospital <11.0 IV: iron 
sucrose 
Oral: ferrous 
fumerate 
Mean: 
11.24 
SD: 
0.7 
Mean: 
11.06 
SD: 
0.63 
Rohina, et al. 
(2012) 
Ahmedaba
d, India 
25 25 Institute of Kidney 
Disease and  
Study Centre 
<7.0 IV: iron 
sucrose 
Oral: ferrous 
sulfate 
Mean: 
11.3 
SD: 
0.7 
Mean: 
10.26 
SD: 
0.77 
Shafi, et al. 
(2012) 
India 10
0 
100 K.J. Somaiya 
Medical College and 
Study Centre 
6.0-10 IV: iron 
sucrose 
Oral: ferrous 
ascorbate 
Mean: 
10.09 
SD: 
0.81 
Mean: 
9.32 
SD: 
0.87 
 
Based on the articles, that was 9 articles 
that fulfilled the requirements as a source 
for the meta-analysis of intra-venous iron 
administration compared to oral iron to in-
creased hemoglobin levels in pregnant wo-
men with anemia. Then the articles that ha-
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ve been obtained would be analyzed using 
RevMan 5.3 and the results would be pre-
sented in the form of a forest plot which can 
be seen in Figure 3. 
The results of the analysis in Figure 3 
showed that there were 9 articles reporting 
that intravenous iron administration was 
one way that affected the increase in hemo-
globin levels in pregnant women with iron-
deficiency anemia. There was a high hete-
rogeneity between experiments (I2 = 91%; p 
<0.001) so that Random Effects Model was 
used. Intravenous iron administration can 
increase hemoglobin levels 0.70 g / dL hig-
her than oral iron administration, which 
was statistically significant (MD 0.70; CI 95 
%: 0.37 to 1.02; p<0.001).  
Figure 4 effect size of intravenous iron 
administration compared to oral iron can be 
seen that the smallest effect size with a sco-
re of 0.04 while having a large effect size 
was 2.10. 
 
Figure 3.Forest Plot of Intravenous Iron Compared to Oral Iron 
 
 
Figure 4. Effect Size of Intravenous Iron Compared to Oral Iron 
 
 
 
 
 
 
 
 
 
 
Figure 5. Funnel Plot of Intravenous Iron Compared to Oral Iron 
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Funnel plots of intravenous iron and oral 
iron to increase hemoglobin levels, plots on 
the right and left sides were not symmetri-
cal with each other and did not form a re-
verse funnel. The left plot has a standard 
error > 0.2 while in the right plot has a 
standard error of > 0.2, this indicated that 
there was a publication bias in the study.  
 
DISCUSSION 
Anemia in pregnancy was a condition of 
mothers with hemoglobin levels below 11 g / 
dL in the first trimester and third trimester 
or <10.5 g% in the second trimester 
(Andriani et al., 2016). Anemia was influ-
enced by many factors, including gestati-
onal age, maternal education, family in-
come, pregnancy intervals, parity, increased 
blood tablet consumption, and history (Pra-
hesti et al., 2016). The occurrence of anemia 
was not always a diagnosis due to the 
underlying disease process, technically, 
anemia was defined as a condition in which 
an individual hemoglobin concentration in 
a count of two standard deviations was 
below the interval reference (Adewoyin, 
2015). 
The last few years, oral iron, intra-
muscular and iron iron preparations have 
been used to treat iron deficiency anemia in 
pregnancy. The first choice in the treatment 
of iron deficiency anemia for almost all 
patients was replacement of oral iron due to 
its effectiveness, safety, and lower costs 
(Renzo et al., 2015). The main problem with 
classic oral iron therapy was poor 
tolerability and up to 40% detrimental to 
the reaction rate (Goonewardene et al., 
2012). The most common complaints were 
nausea, abdominal pain, diarrhea and 
constipation. Severe systemic side effects 
associated with dextran iron and iron 
gluconate which limit intravenous use of 
iron. Sucrose iron was a relatively new drug, 
which was used intravenously to treat iron 
deficiency anemia (Arulkumaran et al., 
2011). 
The results showed that there were 
high heterogeneity between experiments (I2 
= 91%; p <0.001) so that Random Effects 
Model (REM) was used. Intravenous iron 
administration can increase hemoglobin 
levels by 0.70 g/dL higher than oral iron 
administration, which was statistically sig-
nificant (MD 0.70; 95% CI: 0.37 to 1.02; p 
<0.001). These results were supported by 
the study of Khalafallah et al. (2010) which 
stated that intravenous iron was more 
effective than oral iron for the treatment of 
anemia in pregnancy iron deficiency. In 
addition, intravenous iron was safer than 
oral iron. Devasenapathy et al. (2012) 
showed that intravenous iron can be a 
promising therapeutic choice in anemia of 
pregnancy, in addition, this study stated 
that intravenous therapy can be an option 
for increased hemoglobin levels especially 
in anemia during pregnancy that was severe 
or required rapid treatment.  
In addition to hemoglobin levels, 
anemia was closely related to economic 
status. Economic was a determining factor 
in a healthy pregnancy process. Families 
with sufficient economies can check their 
pregnancies on a regular basis, plan delivery 
at health personnels and do other 
preparations properly (Kurniati et al., 
2016). Health awareness was needed 
especially during pregnancy to reduce the 
risk that can occur in the mother and fetus. 
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